Avio Smart Market Stack Limited has entered into a strategic memorandum of understanding with ProClima Services Private Limited to jointly develop and commercialise next-generation biochar-based soil enhancement solutions. Announced on July 29, 2026, the partnership aims to advance regenerative farming, improve soil health, and explore carbon removal opportunities across India by combining ASMS's extensive rural network with ProClima's specialisation in biochar production.

The collaboration focuses on developing scientifically validated biochar-integrated fertiliser formulations designed to enhance soil fertility, improve water retention, and increase crop productivity while enabling long-term carbon sequestration. The companies will undertake research, laboratory analysis proposed at IIT Roorkee, field trials, and agronomic validation across multiple crop varieties, soil types, and agro-climatic conditions. This initiative seeks to create pathways for generating verified carbon credits through biochar application, allowing farmers to benefit from emerging carbon markets.

Strategic Collaboration Details

The partnership integrates distinct capabilities from both organisations to drive commercial deployment of sustainable agricultural technologies.

Dr. Raja Krishna Murthy Morla, Head – Agri Tech Business at Avio Smart Market Stack, stated that agriculture requires solutions improving farm productivity while addressing long-term environmental challenges. He noted the aim to develop innovative biochar-based products supporting healthier soils and measurable climate impact by combining scientific research with their rural ecosystem.

Vijaykumar Rangaraju, Chief Mission Officer at ProClima Services, described biochar as a promising technology for regenerative agriculture and durable carbon removal. He emphasised that partnering with ASMS enables combining advanced climate solutions with deep agricultural reach to accelerate biochar adoption across India's farming ecosystem.

Feedstock and Research Scope

The initiative will evaluate biochar produced from sustainable feedstocks including bamboo, lantana, senna, pine needles, and agricultural residues to determine optimal formulations for commercial deployment. Both companies will work towards developing commercially viable products that support regenerative agriculture, strengthen soil ecosystems, and contribute to India's net-zero ambitions.

What This Means for Stakeholders

The partnership represents a significant diversification move for Avio Smart Market Stack into climate-focused agricultural technology. By leveraging its existing presence in more than 5,000 villages, ASMS positions itself to distribute scientifically validated soil enhancement solutions directly to end-users. For investors, the collaboration signals a strategic pivot towards sustainable agriculture and carbon markets, sectors gaining traction amid global focus on net-zero goals. The potential for verified carbon credit generation introduces a new revenue stream linked to environmental outcomes, aligning agricultural productivity with climate action objectives.

Avio Smart Market Stack has revised its investment disclosure in Huwel Lifesciences Private Limited, updating the total transaction value to ₹7,50,00,400. The company acquired a 2.06% stake in the lifescience entity, correcting an earlier intimation dated April 08, 2026, which had reported a lower investment amount of ₹4,00,00,000.

Investment Details

The revised investment parameters are detailed below:

Transaction Background

The acquisition, which has been completed, was conducted at arm’s length and does not constitute a related party transaction. Avio Smart Market Stack acquired 9,665 equity shares at a price of ₹7,760 per share, including a premium of ₹7,750 per share. The consideration was paid in cash. The company stated that the remaining terms and conditions of the investment remain unchanged.

Target Entity Profile

Huwel Lifesciences Private Limited, incorporated on February 10, 2015, operates in the lifescience and health industry. The entity is engaged in the development, manufacturing, and supply of molecular diagnostic kits, medical devices, and in-vitro diagnostic solutions. Its operations are based in Patancheru, Telangana, India. The target entity serves hospitals, laboratories, and research institutions, providing products for disease detection and healthcare testing.